Stryker Neurovascular
Clinical trials sponsored by Stryker Neurovascular, explained in plain language.
A subsidiary of Stryker, focused on neurovascular medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New coil device aims to seal brain aneurysms without surgery Results expected Nov 2026 (estimated)
-
Mesh tube could seal dangerous brain aneurysms without surgery
Disease control OngoingThis study tests a device called the Surpass Evolve Flow Diverter, a small mesh tube placed inside an artery to redirect blood flow away from a brain aneurysm. The goal is to safely close the aneurysm and prevent it from rupturing. About 248 adults with unruptured, wide-neck aneu…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New brain aneurysm device tracked for 5 years in 500 patients
Disease control OngoingThis study follows 500 people who received the Surpass Evolve flow diverter, a device placed in brain arteries to treat aneurysms. Researchers will track safety and effectiveness for up to 5 years, focusing on stroke risk and aneurysm closure. The goal is to confirm the device wo…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New coil device aims to seal brain aneurysms without surgery
Disease control OngoingThis study is testing a new device called the Citadel Embolization Device, a coil used to block blood flow in brain aneurysms. It involves 150 adults aged 18-80 with unruptured or recently ruptured wide-neck aneurysms. The goal is to see if the device safely and effectively seals…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC